본문으로 건너뛰기
← 뒤로

Suppressive role of SCN4B in the epithelial‑mesenchymal transition of lung adenocarcinoma.

Oncology reports 2026 Vol.55(4)

Guo M, Li H, Zhao Z, Wang Y, Tang J, Zhong B, Zhao Y

📝 환자 설명용 한 줄

The poor prognosis and high mortality rate of non‑small cell lung cancer are largely driven by its aggressive migratory and invasive behavior.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Guo M, Li H, et al. (2026). Suppressive role of SCN4B in the epithelial‑mesenchymal transition of lung adenocarcinoma.. Oncology reports, 55(4). https://doi.org/10.3892/or.2026.9073
MLA Guo M, et al.. "Suppressive role of SCN4B in the epithelial‑mesenchymal transition of lung adenocarcinoma.." Oncology reports, vol. 55, no. 4, 2026.
PMID 41685607

Abstract

The poor prognosis and high mortality rate of non‑small cell lung cancer are largely driven by its aggressive migratory and invasive behavior. Epithelial‑mesenchymal transition (EMT) is a central mechanism conferring these malignant traits. The present study examined the expression profile of the sodium channel β4 subunit () in lung adenocarcinoma (LUAD) and explored its regulatory role in EMT. Transcriptomic data from The Cancer Genome Atlas were analyzed to compare expression between LUAD and normal tissues, and to assess its relationship with TNM clinical stage (I‑IV), overall survival and diagnostic performance using non‑parametric tests, Kaplan‑Meier analysis and receiver operating characteristic curves, respectively. Functional enrichment analysis, including Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, and immune cell infiltration profiling were performed on ‑associated differentially expressed genes. , the A549 and H1299 LUAD cell lines were engineered to overexpress . Viability, migration, invasion and apoptosis were evaluated using Cell Counting Kit‑8 assays, wound healing assays, Transwell assays and flow cytometry. In addition, western blotting was conducted to assess EMT markers, including E‑cadherin, N‑cadherin, Vimentin and Snail. The results demonstrated that expression was markedly reduced in LUAD tissues and low SCN4B expression was associated with unfavorable clinical outcomes. KEGG analysis revealed enrichment of SCN4B‑related genes in the 'cell adhesion molecules' pathway, and SCN4B expression levels differed markedly between TNM tumor (T) pathologic stages T1 and T2. Furthermore, SCN4B overexpression suppressed viability, migration and invasion of A549 and H1299 cells, while promoting apoptosis. Western blotting demonstrated upregulation of E‑cadherin, and downregulation of N‑cadherin, Vimentin and Snail in the overexpression group compared with the empty vector group, indicating inhibition of EMT. In conclusion, low expression was associated with poor prognosis in LUAD. Notably, restoring levels suppressed LUAD cell viability, migration and invasion , accompanied by inhibition of EMT. These findings highlighted as a potential tumor suppressor and a promising therapeutic target for LUAD.

MeSH Terms

Humans; Epithelial-Mesenchymal Transition; Adenocarcinoma of Lung; Gene Expression Regulation, Neoplastic; Lung Neoplasms; Female; Cell Movement; Male; Middle Aged; Voltage-Gated Sodium Channel beta-4 Subunit; Prognosis; Biomarkers, Tumor; Cell Line, Tumor; A549 Cells; Apoptosis; Aged; Cell Proliferation; Neoplasm Staging

같은 제1저자의 인용 많은 논문 (5)